ω-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer, farmasøytisk akseptable salter derav, farmasøytiske preparater derav, og anvendelse av forbindelsene til fremstilling av et medikament for behandling av faste kreftformer

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Natero, Reina, Riedl, Bernd, Scott, William J, Sibley, Robert N, Renick, Joel, Dumas, Jacques, Wood, Jill Elizabeth, Khire, Uday, Smith, Roger A, Monahan, Mary-Katherine, Lowinger, Timothy Bruno
Format:	Patent
Sprache:	nor
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.